Literature DB >> 26912314

Understanding why clinicians should care about danger-associated molecular patterns.

Karim Asehnoune1, Richard S Hotchkiss2, Guillaume Monneret3.   

Abstract

Year:  2016        PMID： 26912314     DOI： 10.1007/s00134-015-4198-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

Review 1.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Authors:  R S Munford; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation.

Authors:  Sara Trabanelli; Darina Ocadlíková; Sara Gulinelli; Antonio Curti; Valentina Salvestrini; Rodolfo de Paula Vieira; Marco Idzko; Francesco Di Virgilio; Davide Ferrari; Roberto M Lemoli
Journal:  J Immunol       Date:  2012-07-02       Impact factor: 5.422

3.  Early daily mHLA-DR monitoring predicts forthcoming sepsis in severe trauma patients.

Authors:  Aurélie Gouel-Chéron; Bernard Allaouchiche; Bernard Floccard; Thomas Rimmelé; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2015-09-10       Impact factor: 17.440

Review 4.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 5.  CD73: a potent suppressor of antitumor immune responses.

Authors:  Paul A Beavis; John Stagg; Phillip K Darcy; Mark J Smyth
Journal:  Trends Immunol       Date:  2012-04-07       Impact factor: 16.687

Review 6.  Immunogenic cell death in cancer therapy.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Oliver Kepp; Laurence Zitvogel
Journal:  Annu Rev Immunol       Date:  2012-11-12       Impact factor: 28.527

Review 7.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

8.  Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

Authors:  Yuting Ma; Sandy Adjemian; Stephen R Mattarollo; Takahiro Yamazaki; Laetitia Aymeric; Heng Yang; João Paulo Portela Catani; Dalil Hannani; Helene Duret; Kim Steegh; Isabelle Martins; Frederic Schlemmer; Mickaël Michaud; Oliver Kepp; Abdul Qader Sukkurwala; Laurie Menger; Erika Vacchelli; Nathalie Droin; Lorenzo Galluzzi; Roman Krzysiek; Siamon Gordon; Philip R Taylor; Peter Van Endert; Eric Solary; Mark J Smyth; Laurence Zitvogel; Guido Kroemer
Journal:  Immunity       Date:  2013-04-04       Impact factor: 31.745

Review 9.  Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.

Authors:  Fabienne Venet; Anne-Claire Lukaszewicz; Didier Payen; Richard Hotchkiss; Guillaume Monneret
Journal:  Curr Opin Immunol       Date:  2013-05-28       Impact factor: 7.486

Review 10.  DAMPs from Cell Death to New Life.

Authors:  Emilie Vénéreau; Chiara Ceriotti; Marco Emilio Bianchi
Journal:  Front Immunol       Date:  2015-08-18       Impact factor: 7.561
View more
  3 in total

Review 1.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

2.  PACMAN trial protocol, Perioperative Administration of Corticotherapy on Morbidity and mortality After Non-cardiac major surgery: a randomised, multicentre, double-blind, superiority study.

Authors:  Karim Asehnoune; Emmanuel Futier; Fanny Feuillet; Antoine Roquilly
Journal:  BMJ Open       Date:  2019-03-23       Impact factor: 2.692

Review 3.  Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.

Authors:  Jinlin Zhang; Wenchen Luo; Changhong Miao; Jing Zhong
Journal:  Front Nutr       Date:  2022-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.